What HCPs believe before it shows up in Rx data.

GNM reveals how physician conviction forms, helping Medical Affairs and Commercial teams identify readiness, resistance and adoption opportunities before they become visible in traditional market data.

Scroll

Powering decisions for global pharmaceutical leaders

Understand physician conviction before adoption becomes visible.

  1. Detect adoption shifts before they become visible in Rx data

    Understand early signals in HCP behavior to anticipate changes in adoption long before traditional data confirms them.

  2. Identify HCPs who truly influence decisions

    Go beyond visibility to pinpoint the HCPs whose evidence-seeking behavior genuinely shapes peer decisions.

  3. Transform insight into strategy

    Turn decoded behavioral signals into clear, actionable strategies across the product lifecycle.

What makes GNM different

20+yrs

of trusted scientific content across 20+ therapeutic areas. The foundation every behavioral signal stands on.

Conviction Intelligence

The intelligence layer between scientific engagement and prescribing behaviour. Reveals how physician conviction forms before it becomes visible in prescribing, market research or competitive data.

1.5M+

Verified HCPs across 6 regions. The infrastructure that makes Conviction Intelligence possible.

Deep engagement across high-value therapeutic areas including Cardiology, Oncology, Neurology, Hematology and Rare Disease.

Enabling you to reach HCPs worldwide, with targeted selection by region and specialty.
World map showing GNM verified HCP distribution across 6 regions North America 739K, Latin America 173K, Europe 212K, MENA 94K, Africa 67K, APAC 215K. Total 1.5 million plus. North America 739K APAC 215K Europe 212K Latin America 173K MENA 94K Africa 67K

Where Conviction Intelligence sits

  • Rx data

    The receipt, not the decision

    Captures what’s done, not what’s forming

  • Market research

    What they tell you, not what they do

    Stated preference, decoupled from action

  • Medical education platforms

    Content consumption, without behavioural intelligence

    Measures what is read, not what clinicians come to believe

  • Conviction Intelligence

    Where physician belief forms

    Signals in real time, while decisions are still fluid

What you can do with Conviction Intelligence

Medical Affairs

  • Identify evidence gaps
  • Prioritise MSL engagement
  • Understand scientific readiness

Commercial

  • Detect emerging adoption signals
  • Identify true behavioural influencers
  • Improve resource allocation

Launch Excellence

  • Compare market readiness
  • Monitor adoption pathways
  • Guide launch investment

Most pharma data tells you what physicians did or said. Conviction Intelligence tells you what they believe, before it shows up in Rx data.

Strategic team reviewing pharmaceutical market analytics around a table

Your market is already telling you what's next.

Understand which clinical questions are gaining momentum, where adoption readiness is highest, and which physicians are helping shape peer decisions.

See it in action

Where we operate

Global coverage. Local understanding.

Our teams operate across major pharmaceutical markets, combining global strategic support with local healthcare intelligence and specialist community access. HCP coverage and regional intelligence sit on the Network page.

Next step

Start with visibility. Add intelligence. Unlock activation.

Talk to an expert

Discuss your market, launch or therapeutic area with a GNM intelligence specialist.